All data are based on the daily closing price as of November 18, 2026
h

HK inno.N

195940.KQ
27.34 USD
-0.06
-0.22%

Overview

Last close
27.34 usd
Market cap
774.65M usd
52 week high
39.98 usd
52 week low
24.51 usd
Target price
45.89 usd

Valuation

P/E
24.6833
Forward P/E
N/A
Price/Sales
1.2349
Price/Book Value
0.7582
Enterprise Value
1.02B usd
EV/Revenue
1.2591
EV/EBITDA
10.8431

Key financials

Revenue TTM
630.73M usd
Gross Profit TTM
261.55M usd
EBITDA TTM
71.65M usd
Earnings per Share
1.1 usd
Dividend
0.31 usd
Total assets
1.31B usd
Net debt
234.28M usd

About

HK inno.N Corporation engages in the pharmaceutical business in South Korea. The company offers prescription drugs for the treatment of gram-positive and gram-negative organisms, enterococcus faecium infections, vancomycin-resistant, acute bacterial sinusitis, bronchitis, neumonia, antibiotics, and infections caused by microorganism; anemia and hemodialysis; diabetes; hypertension, primary hypercholesterinemia, homozygous familial hypercholesterolemia, and hypertension with dyslipidemia; GERD, EE, NERD, GU and H.Pylori; pleural mesothelioma, non-small cell lung cancer, and mesothelioma, and colorectal cancer; and nutrition and intravenous nutrition. It also provides health and beverage products, such as hangover relief, ready to drink, health supplements and health functional foods, as well as active pharmaceutical ingredients. In addition, the company offers beauty products under the bewants, ScalpMed, and KLEDERMA RX brands. It also exports its products to Japan, Southeast Asia, Latin America, Europe, and the Middle East countries. The company has joint research and development agreement with Nextgen Bioscience for NXC680, a candidate compound for treatment of Idiopathic Pulmonary Fibrosis. HK inno.N Corporation was founded in 1984 and is headquartered in Cheongju-si, South Korea.
  • Symbol
    195940.KQ
  • Exchange
    KQ
  • Isin
    N/A
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. Dal-Won Kwak
  • Headquarter
    Cheongju-si
  • Web site
    https://www.inno-n.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top